2026 Pivotal Phase 3 Readout Calendar

Every Phase 3 clinical trial with a primary completion date in 2026.

~3000 rows ~900 KB CSV Updated weekly Worldwide 2026 Free

Download

CSV ↓ JSON ↓

About this dataset

All Phase 3 trials registered on ClinicalTrials.gov with a primary completion date in calendar year 2026. Includes sponsor, drug, indication, sample size, primary endpoint, and any posted preliminary results.

Schema

ColumnDescriptionType
nct_idClinicalTrials.gov NCT identifierstring
brief_titleTrial titlestring
lead_sponsor_nameLead sponsorstring
phaseTrial phasestring
completion_datePrimary completion date (ISO 8601)date
has_resultsWhether results are postedboolean

Sources

ClinicalTrials.gov.

Citation

APA

Drug Landscape. (2026). 2026 Pivotal Phase 3 Readout Calendar (Version 2026.05) [Data set]. Drug Landscape. https://druglandscape.com/datasets/phase-3-readouts-2026

BibTeX

@dataset{DrugLandscape2026Phase3Readouts,
  author       = {Drug Landscape},
  title        = {2026 Pivotal Phase 3 Readout Calendar},
  year         = {2026},
  version      = {2026.05},
  publisher    = {Drug Landscape},
  url          = {https://druglandscape.com/datasets/phase-3-readouts-2026},
  note         = {~3000 rows; source: ClinicalTrials.gov}
}

RIS

TY  - DATA
T1  - 2026 Pivotal Phase 3 Readout Calendar
AU  - Drug Landscape
PY  - 2026
ET  - 2026.05
PB  - Drug Landscape
UR  - https://druglandscape.com/datasets/phase-3-readouts-2026
ER  -

License

Free for any use including commercial, with attribution to Drug Landscape (druglandscape.com). Full terms in our editorial policy.

Other datasets